Diabetes Health Policy Analysis: Public Health Report, Semester 1

This report provides an analysis of diabetes health policies, beginning with a problem statement highlighting the increasing global prevalence and associated challenges of the disease. It then discusses the background of diabetes, including its causes and the progression from autoantibody development to clinical diagnosis. The report outlines the landscape of diabetes, emphasizing the evolution of treatment methods and the persistent need for improved glycemic control. It differentiates between type 1 and type 2 diabetes management, detailing treatment options such as insulin injections, oral drugs, and lifestyle adjustments. The report concludes with recommendations for patients, including the importance of healthy diets, regular exercise, blood glucose monitoring, and awareness of diabetes-related factors like hyperglycemia and stress. Several references are provided to support the analysis.

Diabetes health policy analysis
Problem statement.
• Diabetes is one of the diseases which pose great chronic
problems in the healthcare sectors.
• These include many consequences which are
devastating and yet is increasing globally at a higher rate
and needs to be addressed more carefully failure to
which deaths can increase (Powers et al., 2017).

Background.
•Diabetes is a disease which is brought about by
a high concentrations of sugar or glucose above
the normal levels in blood.
•This is either due to lack of response of body
cells to the insulin being produced in the beta
cells of the pancreas or the pancreas itself may
be producing insufficient amounts of insulin
(Petersmann et al., 2018).

Landscape.
•Diabetes is an autoimmune disease which has gone
through progression stages as described by studies for
over several decades ago from stages of appearing of
autoantibodies until hyperglycemia diagnosis as a clinical
disease and insulin dependence.
•Improvements have been made in the management of
diabetes with exogenous insulin though many patients
have not met clinical glycemic and diabetes goal posing
this condition to be a serious problem to both children
and adults (Colagiuri et al., 2018).

Options.
•Type 1 diabetes is managed by daily
injections with insulin to help in the
control of high glucose levels.
•Type 2 can be managed by issuance of
oral drugs and administration of insulin,
exercise and eating healthy balanced diet
(Carracher, Marathe, & Close, 2018).

Recommendations.
Patients should:
•Take control of their health
•Eat a healthy balanced diet
•Regularly exercise
•Meet their blood glucose closely
•Lead a normal life
•Be knowledgeable on diabetes issues such as
hyperglycemia, stress among other factors and their
effects to blood glucose levels (Pettus & Edelman, 2016).

References.
• Carracher, A. M., Marathe, P. H., & Close, K. L. (2018). Advanced Technologies
and Treatments for Diabetes 2018. Journal of Diabetes, 10(7), 541-545.
• Colagiuri, S., Matthews, D., Leiter, L. A., Chan, S. P., Sesti, G., & Marre, M.
(2018). The place of gliclazide MR in the evolving type 2 diabetes landscape: A
comparison with other sulfonylureas and newer oral antihyperglycemic agents.
Diabetes Research and Clinical Practice, 143, 1-14.
• Petersmann, A., Nauck, M., Müller-Wieland, D., Kerner, W., Müller, U. A.,
Landgraf, R., … Heinemann, L. (2018). Definition, classification and diagnostics
of diabetes mellitus. LaboratoriumsMedizin, 42(3), 73-79.
• Pettus, J., & Edelman, S. V. (2016). Recommendations for Using Real-Time
Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1
Diabetes. Journal of Diabetes Science and Technology, 11(1), 138-147.
• Powers, M. A., Bardsley, J., Cypress, M., Duker, P., Funnell, M. M., Fischl, A. H.,
… Vivian, E. (2017). Diabetes Self-management Education and Support in Type 2
Diabetes. The Diabetes Educator, 43(1), 40-53.